These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33234243)

  • 1. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
    Cai B; Kasikara C
    Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
    Myers KV; Amend SR; Pienta KJ
    Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAM receptors in cardiovascular disease.
    McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
    Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
    Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
    Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
    Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
    Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
    Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
    Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
    Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
    Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
    Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
    J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
    Peeters MJW; Rahbech A; Thor Straten P
    Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.
    Tondo G; Perani D; Comi C
    Dis Markers; 2019; 2019():2387614. PubMed ID: 31636733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
    Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
    Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
    Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
    Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function.
    Evans AL; Blackburn JWD; Taruc K; Kipp A; Dirk BS; Hunt NR; Barr SD; Dikeakos JD; Heit B
    Mol Biol Evol; 2017 Jul; 34(7):1613-1628. PubMed ID: 28369510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
    Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
    Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
    Burstyn-Cohen T; Fresia R
    Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment.
    Zhou L; Matsushima GK
    Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
    Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
    Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.
    Davra V; Kumar S; Geng K; Calianese D; Mehta D; Gadiyar V; Kasikara C; Lahey KC; Chang YJ; Wichroski M; Gao C; De Lorenzo MS; Kotenko SV; Bergsbaken T; Mishra PK; Gause WC; Quigley M; Spires TE; Birge RB
    Cancer Res; 2021 Feb; 81(3):698-712. PubMed ID: 33239426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
    Shafit-Zagardo B; Gruber RC; DuBois JC
    Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.